Related Experiment Video
Updated: Aug 13, 2026
11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
High-throughput techniques in breast cancer: a clinical perspective
Enrique Espinosa1, Andrés Redondo, Juan Angel Fresno Vara
1Service of Medical Oncology, Hospital La Paz - Universidad Autónoma, Paseo de la Castellana, 261, 28046 Madrid, Spain. eespinosa00@terra.es
European Journal of Cancer (Oxford, England : 1990)
|January 25, 2006
Summary
High-throughput technologies offer advanced insights into patient response to cancer therapies, improving treatment predictions. Further research is needed to integrate these powerful diagnostic tools into routine clinical practice.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Classical methods provide limited prognostic and predictive information in cancer care.
- High-throughput technologies like DNA microarrays and proteomics offer enhanced patient data.
- These advanced techniques can predict response to adjuvant therapies.
Purpose of the Study:
- To explore the role of high-throughput technologies in improving cancer patient prognostics.
- To assess the potential of these methods in predicting response to hormonal and adjuvant chemotherapy.
- To highlight the need for further refinement before clinical integration.
Main Methods:
- Utilizing DNA microarrays, RT-PCR, and proteomics for data acquisition.
- Analyzing tumor biology, prognosis, and treatment response in breast cancer studies.
- Focusing on prediction of response to specific therapeutic agents.
Main Results:
- High-throughput technologies provide accurate predictions of patient response to adjuvant therapy.
- These methods can identify patients likely to resist or benefit from specific treatments.
- Current applications focus on hormonal therapy and adjuvant chemotherapy research.
Conclusions:
- High-throughput technologies significantly enhance prognostic and predictive capabilities beyond classical parameters.
- These advanced tools are crucial for clinical investigation, especially in optimizing adjuvant treatments.
- Collaboration between clinicians, pathologists, and researchers is essential for integrating these complex diagnostic tools into daily practice.
